Biogen's total assets for Q3 2025 were $29.21B, an increase of 3.10% from the previous quarter. BIIB total liabilities were $11.00B for the fiscal quarter, a 2.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.